Cargando…

Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State

To address diminishing pediatric vaccination rates resulting from the COVID-19 pandemic, the Public Readiness and Emergency Preparedness (PREP) Act allows pharmacists, technicians, and pharmacy interns to administer any vaccine that the Advisory Committee on Immunization Practices (ACIP) guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeirnan, Kimberly Caye, Motzner, Madison Shea, Kherghehpoush, Sorosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788090/
https://www.ncbi.nlm.nih.gov/pubmed/36548312
http://dx.doi.org/10.3390/pharmacy10060156
_version_ 1784858670420459520
author McKeirnan, Kimberly Caye
Motzner, Madison Shea
Kherghehpoush, Sorosh
author_facet McKeirnan, Kimberly Caye
Motzner, Madison Shea
Kherghehpoush, Sorosh
author_sort McKeirnan, Kimberly Caye
collection PubMed
description To address diminishing pediatric vaccination rates resulting from the COVID-19 pandemic, the Public Readiness and Emergency Preparedness (PREP) Act allows pharmacists, technicians, and pharmacy interns to administer any vaccine that the Advisory Committee on Immunization Practices (ACIP) guidelines recommend for all patients aged 3 years and older. A survey was conducted to evaluate the role of pharmacy personnel in the community setting providing immunizations for the pediatric patients. Sixty-seven pharmacies were contacted in a state where pharmacists are allowed to administer vaccinations to any patient over the age of six months. Of the 58 respondent pharmacies offering vaccinations for pediatric patients, the most commonly reported vaccines included influenza (97%), tetanus, diphtheria, and pertussis (88%), hepatitis (71%), human papillomavirus (69%), meningococcal vaccines (66%), polio (45%), and Haemophilus influenzae type b vaccine (40%). Nearly all respondent pharmacies (56/58) reported having at least one of the ACIP-recommended routine childhood vaccinations available for patients under the age of 18. Community pharmacies are well-positioned to administer routine vaccinations to pediatric patients and address declining pediatric vaccination rates.
format Online
Article
Text
id pubmed-9788090
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97880902022-12-24 Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State McKeirnan, Kimberly Caye Motzner, Madison Shea Kherghehpoush, Sorosh Pharmacy (Basel) Brief Report To address diminishing pediatric vaccination rates resulting from the COVID-19 pandemic, the Public Readiness and Emergency Preparedness (PREP) Act allows pharmacists, technicians, and pharmacy interns to administer any vaccine that the Advisory Committee on Immunization Practices (ACIP) guidelines recommend for all patients aged 3 years and older. A survey was conducted to evaluate the role of pharmacy personnel in the community setting providing immunizations for the pediatric patients. Sixty-seven pharmacies were contacted in a state where pharmacists are allowed to administer vaccinations to any patient over the age of six months. Of the 58 respondent pharmacies offering vaccinations for pediatric patients, the most commonly reported vaccines included influenza (97%), tetanus, diphtheria, and pertussis (88%), hepatitis (71%), human papillomavirus (69%), meningococcal vaccines (66%), polio (45%), and Haemophilus influenzae type b vaccine (40%). Nearly all respondent pharmacies (56/58) reported having at least one of the ACIP-recommended routine childhood vaccinations available for patients under the age of 18. Community pharmacies are well-positioned to administer routine vaccinations to pediatric patients and address declining pediatric vaccination rates. MDPI 2022-11-22 /pmc/articles/PMC9788090/ /pubmed/36548312 http://dx.doi.org/10.3390/pharmacy10060156 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
McKeirnan, Kimberly Caye
Motzner, Madison Shea
Kherghehpoush, Sorosh
Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
title Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
title_full Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
title_fullStr Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
title_full_unstemmed Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
title_short Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
title_sort examining routine pediatric vaccination availability in community pharmacies in washington state
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788090/
https://www.ncbi.nlm.nih.gov/pubmed/36548312
http://dx.doi.org/10.3390/pharmacy10060156
work_keys_str_mv AT mckeirnankimberlycaye examiningroutinepediatricvaccinationavailabilityincommunitypharmaciesinwashingtonstate
AT motznermadisonshea examiningroutinepediatricvaccinationavailabilityincommunitypharmaciesinwashingtonstate
AT kherghehpoushsorosh examiningroutinepediatricvaccinationavailabilityincommunitypharmaciesinwashingtonstate